Microchip Technology (MCHP) announces Q2 FY2026 results via 8‑K
Microchip Technology Incorporated furnished an 8‑K to announce its results of operations for the second quarter of fiscal year 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Microchip Technology Incorporated furnished an 8‑K to announce its results of operations for the second quarter of fiscal year 2026. The disclosure was provided under Item 2.02 (Results of Operations and Financial Condition) and, as stated, is being furnished pursuant to General Instruction B(2) and is not deemed filed under Section 18 of the Exchange Act.
The company attached a press release as Exhibit 99.1 titled “Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2026.”
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Microchip Technology (MCHP) report in its latest 8‑K?
It announced results for Q2 fiscal 2026 and furnished a corresponding press release as Exhibit 99.1.
Under which item did MCHP furnish this information?
The disclosure was furnished under Item 2.02: Results of Operations and Financial Condition.
Is the Q2 FY2026 information considered filed with the SEC?
No. It was furnished pursuant to General Instruction B(2) and is not deemed filed under Section 18.
What exhibit contains the detailed financial results?
Exhibit 99.1: “Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2026.”
When was the announcement made?
The company announced its Q2 FY2026 results on November 6, 2025.
What securities are listed for Microchip Technology?
Common Stock (MCHP) and Depositary Shares for 7.50% Series A Mandatory Convertible Preferred (MCHPP) on Nasdaq.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
(Exact Name Of Registrant As Specified In Its Charter) | ||
| (State Or Other Jurisdiction Of Incorporation) | (Commission File No.) | (IRS Employer Identification No.) | ||||||
(Address Of Principal Executive Offices, Including Zip Code)
(480 ) 792-7200
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||||||
| (Nasdaq Global Select Market) | ||||||||
| (Nasdaq Global Select Market) | ||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition
The information pursuant to Item 2.02 in this report on Form 8-K is being furnished as contemplated by General Instruction B(2) to Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.
On November 6, 2025, we announced the results of our operations for the second quarter of fiscal year 2026. The complete release is attached to this report as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits
| (d) | Exhibits | |||||||
| The following exhibits are provided as part of this report: | ||||||||
| Exhibit Number | Exhibit Description | |||||||
| 99.1 | Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2026 | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MICROCHIP TECHNOLOGY INCORPORATED | |||||
Date: November 6, 2025 | By: /s/ J. Eric Bjornholt | ||||
| J. Eric Bjornholt | |||||
| Senior Vice President and Chief Financial Officer | |||||